Enanta Pharmaceuticals





Ebitda Изменить Дата
AbbVie USD 3.52B 828M 2025-09
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD -2.69M 4.73M 2025-03
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Immunic USD -22.78M 753K 2024-06
Incyte USD 414.5M 92.42M 2025-12
Insmed USD -314.19M 31.48M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
J&J USD 9.52B 389M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Merck USD 8.39B 1.97B 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09
Novavax USD -117.12M 55.66M 2024-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD 20.63M 53.74M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Enanta Pharmaceuticals - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2026.